Result Summaries: GW274150
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| RA4104917 | phase 2 | A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects. (0 citation(s)) |  |